...
首页> 外文期刊>Oncogene >Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer
【24h】

Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer

机译:金属蛋白酶-1的组织抑制剂通过癌症中的YAP / TAZ激活促进细胞增殖

获取原文
           

摘要

Tissue inhibitor of metalloproteinase-1 (TIMP-1), a member of the TIMP family (TIMP-1 to 4), is highly expressed in various types of cancer and forms a complex with its receptor CD63 and Integrin ?1. However, the precise oncogenic mechanism of TIMP-1 remains unclear. Yes-associated protein (YAP) and transcriptional co-activator with PDZ binding motif (TAZ) are transcription co-activators enhancing the transcription of specific genes related to cell proliferation. But the mechanism of aberrant YAP/TAZ activation in cancer is not fully understood. Here, we showed that TIMP-1 activates YAP/TAZ as novel downstream targets to promote cell proliferation. The TIMP-1-CD63-lntegrin ?1 axis activates Src and promotes RhoA-mediated F-actin assembly, leading to LATS1/2 inactivation. This results in under-phosphorylation, protein stabilization and nuclear translocation of YAP/TAZ (YAP/TAZ activation); CTGF production; and cell proliferation. Furthermore, the TIMP-1-YAP/TAZ axis is aberrantly activated in various types of cancer cells or tissues. TIMP-1 knockdown inhibits cell proliferation through YAP/TAZ inactivation in cancer cells. This study found that TIMP-1 accelerates cell proliferation through YAP/TAZ activation in cancer, and suggests the TIMP-1-YAP/TAZ axis may be a novel potential drug target for cancer patients.
机译:金属蛋白酶-1(TIMP-1)的组织抑制剂(TIMP-1至4)在各种类型的癌症中高度表达,并与其受体CD63和整合素β1形成复合物。但是,TIMP-1的确切致癌机制仍不清楚。是相关蛋白(YAP)和具有PDZ结合基序(TAZ)的转录共激活因子是转录共激活因子,可增强与细胞增殖相关的特定基因的转录。但是,尚未完全了解癌症中异常的YAP / TAZ激活的机制。在这里,我们表明TIMP-1激活YAP / TAZ作为促进细胞增殖的新型下游靶标。 TIMP-1-CD63-ntegrinβ1轴激活Src并促进RhoA介导的F-肌动蛋白装配,从而导致LATS1 / 2失活。这导致YAP / TAZ的磷酸化不足,蛋白质稳定和核易位(YAP / TAZ激活); CTGF生产;和细胞增殖。此外,TIMP-1-YAP / TAZ轴在各种类型的癌细胞或组织中被异常激活。 TIMP-1敲低通过癌细胞中的YAP / TAZ失活抑制细胞增殖。这项研究发现TIMP-1通过癌症中的YAP / TAZ激活来促进细胞增殖,并暗示TIMP-1-YAP / TAZ轴可能是癌症患者的新型潜在药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号